Nico: Real World Evidence in Advanced Melanoma; A National Prospective Non-Interventional Study of Nivolumab Monotherapy or in Combination with Ipilimumab in Patients with Advanced Melanoma and in Patients with Adjuvant Nivolumab Therapy

被引：0

作者：

Schadendorf, Dirk ^{[1
]}

Eigertler, Thomas ^{[2
]}

Mohr, Peter ^{[3
]}

Weichenthal, Michael ^{[4
]}

Goeppner, Daniela ^{[5
]}

Haferkamp, Sebastian ^{[6
]}

Herber, Martin ^{[7
]}

Meier, Friedegund ^{[8
,9
]}

Meiss, Frank ^{[10
]}

Pfoehler, Claudia ^{[11
]}

Schneider, Stefan W. ^{[12
]}

Terheyden, Patrick ^{[13
]}

Ulrich, Lens ^{[14
]}

Utikal, Jochen ^{[15
]}

Weishaupt, Carsten ^{[16
,17
,18
,19
]}

Gutzmer, Ralf ^{[20
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol Venerol & Allergol, Essen, Germany

[2] Eberhard Karls Univ Tuebingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany

[3] Elbe Clin Buxtehude, Buxtehude, Germany

[4] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany

[5] Justus Liebig Univ, Clin Dermatol & Allergol, Giessen, Germany

[6] Univ Regensburg, Dept Dermatol, Regensburg, Germany

[7] Bristol Myers Squibb GmbH & Co KGaA, Munich, Germany

[8] Tech Univ Dresden, Dresden Univ Hosp, Dept Dermatol, Dresden, Germany

[9] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany

[10] Univ Freiburg, Fac Med, Med Ctr, Dept Dermatol, Freiburg, Germany

[11] Saarland Univ Hosp, Dept Dermatol, Homburg, Germany

[12] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany

[13] Univ Lubeck, Dept Dermatol, Lubeck, Germany

[14] Harzklinikum Dorothea Christiane Erxleben, Dept Dermatol, Quedlinburg, Germany

[15] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany

[16] Univ Hosp Muenster, Dept Med Haematol A, Munster, Germany

[17] Univ Hosp Muenster, Dept Haemostaseol, Munster, Germany

[18] Univ Hosp Muenster, Dept Oncol, Munster, Germany

[19] Univ Hosp Muenster, Dept Pneumol, Munster, Germany

[20] Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, Hannover, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

320

引用

页码：175 / 175

页数：1

共 50 条

[21] Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia
Maeda, Takuya
Hiura, Azusa
Uehara, Jiro
Toyoshima, Rino
Nakagawa, Tomoe
Yoshino, Koji
EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (05) : 662 - 664
[22] Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Sznol, Mario
Ferrucci, Pier Francesco
Hogg, David
Atkins, Michael B.
Wolter, Pascal
Guidoboni, Massimo
Lebbe, Celeste
Kirkwood, John M.
Schachter, Jacob
Daniels, Gregory A.
Hassel, Jessica
Cebon, Jonathan
Gerritsen, Winald
Atkinson, Victoria
Thomas, Luc
McCaffrey, John
Power, Derek
Walker, Dana
Bhore, Rafia
Jiang, Joel
Hodi, F. Stephen
Wolchok, Jedd D.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3815 - +
[23] Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naive and pretreated patients with advanced melanoma within the German noninterventional study NICO
Gutzmer, R.
Eigentler, T.
Mohr, P.
Weichenthal, M.
Duecker, P.
Gebhardt, C.
Goeppner, D.
Grimmelmann, I.
Haferkamp, S.
Kaehler, K. C.
Meier, F.
Pfoehler, C.
Sickmann, T.
Sindrilaru, A.
Terheyden, P.
Ugurel, S.
Ulrich, J.
Utikal, J.
Weishaupt, C.
Schadendorf, D.
ANNALS OF ONCOLOGY, 2021, 32 : S894 - S895
[24] International experience of ipilimumab and nivolumab in patients with advanced melanoma
Serra-Bellver, P.
Versluis, J. M.
Oberoi, H. K.
Slattery, T. D.
Khan, Y.
Patrinelly, J. R.
da Silva, I. Pires
Martinez-Vila, C.
Cook, N.
Graham, D. M.
Zhou, C.
Gupta, A.
Fernandez, A. M. Arance
Johnson, D. B.
Long, G. V.
Pickering, L.
Larkin, J.
Blank, C. U.
Lorigan, P.
ANNALS OF ONCOLOGY, 2020, 31 : S747 - S748
[25] Cutaneous manifestations of ipilimumab, nivolumab and pembrolizumab therapy in patients with advanced melanoma
Kumar, Anagha Bangalore
Bryce, Alan
Vishnu, Prakash
Markovic, Svetomir
McEvoy, Marian
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB188 - AB188
[26] Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma
Urba, Walter J.
Martin-Algarra, Salvador
Callahan, Margaret
Wolchok, Jedd D.
Sharfman, William H.
Sosman, Jeffrey A.
Bhatia, Shailender
Hwu, Wen-Jen
Gajewski, Thomas F.
Slingluff, Craig L.
Shen, Yun
Horak, Christine E.
Hodi, F. Stephen
CANCER RESEARCH, 2015, 75
[27] COST EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED MELANOMA PATIENTS IN ENGLAND
Lee, D.
Amadi, A.
Sabater, J.
Ellis, J.
Johnson, H.
Roskell, N.
Meng, Y.
Patterson, K.
VALUE IN HEALTH, 2016, 19 (07) : A731 - A731
[28] A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
Postow, Michael A.
Knox, Susan J.
Goldman, Debra A.
Elhanati, Yuval
Mavinkurve, Vikram
Wong, Phillip
Halpenny, Darragh
Reddy, Sunil K.
Vado, Kenya
McCabe, Danielle
Ramirez, Kristen Aufiero
Macri, Mary
Schwarzenberger, Paul
Ricciardi, Toni
Ryan, Aileen
Venhaus, Ralph
Momtaz, Parisa
Shoushtari, Alexander N.
Callahan, Margaret K.
Chapman, Paul B.
Wolchok, Jedd D.
Subrahmanyam, Priyanka B.
Maecker, Holden T.
Panageas, Katherine S.
Barker, Christopher A.
CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3193 - 3201
[29] SAFETY PROFILE OF NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI) COMBINATION THERAPY IN PATIENTS WITH ADVANCED MELANOMA (MEL)
Sznol, Mario
Ferrucci, Pier
Hogg, David
Atkins, Michael
Wolter, Pascal
Guidoboni, Massimo
Lebbe, Celeste
Kirkwood, John
Schachter, Jacob
Daniels, Gregory
Hassel, Jessica
Cebon, Jonathan
Gerritsen, Winald
Atkinson, Victoria
Thomas, Luc
Mccaffrey, John
Power, Derek
Jiang, Joel
Hodi, Stephen
Wolchok, Jedd
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 118 - 118
[30] Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome.
Cocorocchio, Emilia
Gandini, Sara
Nezi, Luigi
Manzo, Teresa
Mazzarella, Luca
Barberis, Massimo
Lanfrancone, Luisa
Pala, Laura
Conforti, Fabio
Pennacchioli, Elisabetta
Orsolini, Gianmarco
Fierro, Maria Teresa
Quaglino, Pietro
Senetta, Rebecca
Caliendo, Virginia
Stucchi, Concetta Riviello Sara
Macandog, Angeli Dominique
Frige, Gianmaria
Ferrucci, Pier Francesco
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →